RECEIVED DATE (will be automatically inserted after manuscript is accepted). A synthetic route to enantiopure cis-2,4-disubstituted and 2,4-bridged piperidines is reported, the key step being a stereoselective conjugate addition of an organocuprate to a phenylglycinol-derived unsaturated lactam bearing a substituent at the 8a-position.
Aminoalcohol-derived oxazolopiperidone lactams are exceptionally versatile building blocks for the enantioselective construction of structurally diverse piperidine-containing natural products and bioactive compounds. 1 These lactams allow the substituents to be introduced at the different ring positions in a regio-and stereocontrolled manner, providing easy access to enantiopure polysubstituted piperidines bearing virtually any type of substitution pattern. 2 In particular, the conjugate addition to α,β-unsaturated oxazolopiperidone lactams allows the stereocontrolled formation of a C-C bond at the piperidine 4-position, and has successfully been used to generate either cis or trans 3,4-disubstituted enantiopure piperidine-containing derivatives, including the antidepressant drug (-)-paroxetine, 3 cis-fused perhydrocycloalka[c]pyridines, 4 and the indole alkaloid (+)-uleine.
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To further expand the potential of these lactams we decided to explore a synthetic route to enantiopure 2,4-bridged piperidine derivatives, as outlined in Scheme 1. The key step would be the stereocontrolled introduction of an appropriate unsaturated chain at the 4-position of the piperidine ring by conjugated addition of an organocuprate to an unsaturated lactam A bearing an unsaturated substituent at the 2-position. A subsequent ring-closing metathesis from the resulting cis-2,4-disubstituted piperidine derivative would lead to the target bridged azabicyclo.
SCHEME 1. Synthetic Strategy
It has previously been established 6 that the conjugate addition of organocuprates to unsaturated oxazolopiperidone lactams B (when R = H) is highly stereoselective as a consequence of the conformational rigidity of the bicyclic system. The nucleophilic attack occurs under stereoelectronic control 7 on the exo face, axial to the electrophilic carbon of the conjugate double bond (Figure 1 ). 8 However, it could be expected 9 a priori that the presence of a substituent at the angular position (R ≠ H) could alter the stereochemical outcome of the conjugate addition as a consequence of the 1,3-syn diaxial interactions between this substituent and the incoming nucleophile. For this reason, to evaluate the viability of our synthetic plan we decided to carry out a preliminary study on the stereoselectivity of similar conjugate addition reactions from the model, more easily accessible, unsaturated lactams 3a and 3b. These lactams were prepared, 10 via the corresponding selenides 2 (diastereomeric mixtures), from the known lactams 1a and 1b 11 (Scheme 2). The easily removable benzyloxy-carbonyl electron-withdrawing group was used to enhance the reactivity of the conjugated system. The conjugate addition of a vinyl group to lactam 3a was satisfactorily accomplished (62% overall yield from 2a) with vinylmagnesium bromide in the presence of LiCl, CuI, and trimethylsilyl chloride 13 in THF. The high exo facial stereoselectivity of the conjugate addition was confirmed after removal of the benzyloxycarbonyl substituent present in 4a by hydrogenolysis, which took place with simultaneous hydrogenation of the vinyl group, followed by thermal decarboxylation. Under these conditions a 93:7 mixture (calculated by NMR) of lactam 7a and its C-7 epimer was obtained (see Table 1 ).
SCHEME 2. Conjugate Addition to 8a-Substituted Unsaturated Oxazolopiperidone Lactams
Under the same conditions the sterically more demanding 8a-phenyl substituted lactam 3b gave a similar result: the conjugate addition of a vinyl residue took place in 61% yield (from 2b) and the subsequent debenzyloxycarbonylation afforded (73%) a 94:6 diastereomeric mixture of 7b and its C-7 epimer.
Similar conjugate additions of allylmagnesium chloride to unsaturated lactams 3a and 3b took place with lower stereoselectivity and, after removal of the benzyloxycarbonyl group as in the above series, lactams 8a and 8b were obtained along with the corresponding C-7 epimers (78:22 and 85:15 ratio, respectively) in acceptable overall yield (50% from 2a; 65% from 2b).
A moderate stereoselectivity was also observed in the conjugate addition of the organocuprate derived from phenylmagnesium chloride to 3a: a 84:16 mixture of lactam 9a and its C-7 epimer was isolated in 51% overall yield from 2a.
In contrast, somewhat surprisingly, the conjugate addition of this organocuprate to the 8a-phenyl substituted lactam 3b took place in excellent yield and very high exo stereoselectivity (Table 1) , ultimately leading to lactam 9b in 60% overall yield (from 2b). A π-stacking interaction between the incoming-and 8a-phenyl groups could account for the high stereoselectivity. To illustrate the synthetic usefulness of the above methodology, the phenyl-substituted lactams 9a and 9b were converted to enantiopure cis-2,4-disubstituted piperidines as shown in Scheme 3. Thus, treatment of lactams 9 with LiAlH 4 brought about both the reduction of the amide carbonyl group and the reductive opening of the oxazolidine ring, which took place with complete retention of configuration, 14 to give piperidines 10a and 10b. The cis-relationship of the piperidine substituents at C-2 and C-4 in 10 was evident from the multiplicity of the axial 2 and 4 protons in the NMR spectra (see Supporting Information), thus confirming the stereochemical outcome of the above conjugate additions. A subsequent debenzylation in the presence of (Boc) 2 O gave enantiopure piperidines 11a and 11b. The above results made evident that the presence of a substituent at the angular 8a-position has little effect on the stereoselectivity of the conjugate addition. However, to access bridged piperidine derivatives following the strategy outlined in Scheme 1, we decided to take advantage of the higher stereoselectivity of the vinyl conjugate additions and chose starting lactams A bearing an allyl or 3-butenyl substituent at the 8a-position, which should ultimately lead to 6,6 and 6,7 bridged azabicyclic systems, respectively.
The synthetic sequence is outlined in Scheme 4. The required unsaturated lactams 14 10 were prepared from lactams 12a 15 and 12b 16 via the corresponding selenides 13. As could be expected from the above model experiments, the conjugate addition of the organocuprate derived from vinylmagnesium bromide to crude lactams 14 took place in good yield (~60% from 13) and excellent facial diastereoselectivity to give the exo compounds 15 as C-6 epimeric mixtures (only trace amounts of C-7 endo epimers were detected by NMR), which were directly cyclized (~80% yield) in the presence of the second generation Grubbs catalyst. 17 A subsequent catalytic hydrogenation of the resulting bridged derivatives 16 brought about both the reduction of the C-C double bond and debenzylation to lead, after thermal decarboxylation, to tricyclic lactams 17a (78%) and 17b (83%). In the 6,7 bridged series, lactam 17b was converted to the enantiopure 7-azabicyclo [4.3.1] decane (B-homomorphan) 19b (58% overall yield) by alane reduction followed by hydrogenolysis in presence of (Boc) 2 O. 18 However, in 17a the reductive cleavage of the C-O bond of the oxazolidine ring was more difficult, probably because the process involves the bridgehead carbon of a 6,6 bridged system. In this series, alane reduction of 17a caused only the reduction of the lactam carbonyl. A subsequent prolonged (48 h) treatment of the resulting tricyclic amine with Et 3 SiH-TiCl 4 led to bicyclic amine 18a (48% overall yield from 17a), which was then converted to the enantiopure 2-azabicyclo [3.3.1] nonane (morphan) 19a as in the above 6,7 bridged series. 19 Alternatively, in the Bhomomorphan series, tricyclic lactam 17b was converted to lactam 21 in two steps (65% overall yield) as depicted in Scheme 4. In summary, the exo facial stereoselectivity observed in the conjugate addition of organocuprates to 8a-unsubstituted unsaturated oxazolopiperidone lactams B (R = H) is maintained in the 8a-substituted derivatives, in particular when the incoming group is vinyl. By choosing the appropriate substituent at the 8a position in the starting oxazolopiperidone and the appropriate organocuprate in the conjugate addition step, the reported methodology provides a versatile route to enantiopure cis-2,4-disubstituted and 2,4-bridged piperidines. 20 
Experimental Section
General Procedure for the Conjugate Addition to Unsaturated Lactams (with 4a as an example). LiCl (189 mg, 4.5 mmol) was heated at 80 ºC for 1 h under vacuum (10-15 mm Hg) in a three-necked, 500 mL round-bottomed flask. Then, CuI (357 mg, 4.5 mmol) and THF (5 mL) were added at rt, and the mixture was stirred at rt for 5 min. The suspension was cooled at -78 ºC, and vinylmagnesium bromide (1 M in THF, 4.5 mL), TMSCl (0.57 mL, 4.5 mmol), and the crude of unsaturated lactam 3a (1.8 mmol) in THF (8 mL) were successively added. The resulting mixture was stirred at -78 ºC for 20 h. The reaction was quenched with saturated aqueous NH 4 Cl, and the organic layer was extracted with EtOAc. The combined organic extracts were dried and concentrated. Flash chromatography (1:4 EtOAc-hexane) gave lactams 4a (major) and 7-epi-4a as mixtures of C-6 epimers (508 mg, 62% overall yield from 2a). 4a (major C-6 epimer): IR (NaCl) 1665, 1744 cm , 73.64; H, 6.44; N, 3.58. Found: C, 73.30; H, 6.58; N, 3.51. General Procedure for the Ring-closing Metathesis Reaction (with 16a as an example). Second-generation Grubbs catalyst (3 mg) was added to a solution of lactams 15a (20 mg, 0.05 mmol) in CH 2 Cl 2 (7 ml). The mixture was stirred at rt for 2 h, concentrated, and purified by flash column chromatography (1:9 to 1:4 EtOAc-hexane) to yield tricyclic lactam 16a as a mixture of C-6 epimers (ratio 2:1, 16 mg, 80% yield). 16a (major): IR (NaCl) 1659, 1734 cm Supporting Information Available: Experimental procedures and full spectroscopic data for all compounds, and copies of 1 H and 13 C NMR spectra of all new compounds. This material is available free of change via the Internet at http://pubs.acs.org.
